Clot-busting drug for mild stroke symptoms
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether giving a clot-busting drug to people with mild stroke symptoms (but no limb weakness) can improve recovery. It aims to see if this treatment is safe and helpful for this specific group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke within the last 4.5 hours, or woke up with stroke symptoms and can be treated within 4.5 hours from the middle of your sleep time.
- You are older than 18 years.
- Your stroke symptoms are mild (NIHSS score 5 or less) and you have no weakness in your arms or legs, but you have at least one symptom like vision problems, facial droop, trouble speaking, or numbness.
- You have not had major bleeding, recent surgery, or certain blood-thinning medications that would make the treatment unsafe.
- Your blood pressure is not too high (below 180/100 mmHg) and your blood sugar is within a safe range.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a clot-busting drug called tenecteplase for people having a disabling ischemic stroke (a clot blocking blood flow to the brain). It aims to see if the drug can help improve recovery when given within 4.5 hours of symptoms starting.
This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.
This study tests whether a clot-busting medicine given through a vein can help people who have had a stroke in the last 3 months and are now having another stroke. The goal is to see if this treatment is safe and improves recovery.
This trial tests whether a clot-busting drug given through a vein can safely and effectively treat strokes in people who also have active cancer. It aims to see if this treatment can improve recovery without increasing bleeding risks.
This study looks at whether giving a clot-busting medicine (IV thrombolysis) is safe and effective for people who have had a stroke and also recently took a direct oral anticoagulant (DOAC). If you've taken a DOAC in the last 48 hours, this trial may help doctors decide the best treatment for you.
This study tests whether giving a clot-busting medicine through an IV can help people who have had a stroke while taking a common blood thinner (apixaban, dabigatran, edoxaban, or rivaroxaban). It may be an option if your last dose of the blood thinner was 12 to 48 hours before the stroke and you arrive at the hospital within 4.5 hours of symptoms starting.
Hear when a new Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.